Methods applied to the in vitro primary toxicology testing of natural products: State of the art, strengths, and limits

Planta Medica

Volumn 80, Issue 14, 2014, Pages 1210-1226

  Bunel, Valérian ^a   Ouedraogo, Moustapha ^b   Nguyen, Anh Tho ^a   Stévigny, Caroline ^a   Duez, Pierre ^a,c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^c UNIVERSITY OF MONS   (Belgium)

Author keywords

biological assays; cytotoxicity; guidelines; natural products; pitfalls; toxicity screening

Indexed keywords

ANTINEOPLASTIC AGENT; PLANT EXTRACT;

CELL DEATH; CELL PROLIFERATION; DRUG DEVELOPMENT; DRUG EFFECTS; HUMAN; IN VITRO STUDY; NEOPLASMS; PHYTOTHERAPY; PROCEDURES;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DEATH; CELL PROLIFERATION; DRUG DISCOVERY; HUMANS; IN VITRO TECHNIQUES; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84930486753     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1360273     Document Type: Review

References (185)

1. Cragg G. M., Boyd M. R., Cardellina J. H. II, Newman D. J., Snader K. M., Cloud T. G. Ethnobotany and drug discovery: the experience of the US National Cancer Institute. In: Chadwick D. J., Marsh J. editors Ethnobotany and the search for new drugs. Chichester Wiley: 1994; 178 196
2. Evans D., Evans W., Trease G. Pharmacognosy, 16th edition. Amsterdam Saunders Ltd.: 2009
3. Nguyen A. T., Duez P. Cytotoxic-anticancer drugs from medicinal plants. In: Matsumoto T. editor Phytochemistry research progress. New York Nova Science Publishers, Inc.: 2008; 193 208
4. Verpoorte R., Houghton P. J., Heinrich M., Mukherjee P. K., Hirschmann G. S., van Staden J., Yesilada E. Editorial. J Ethnopharmacol: 2006; 103 309 310
5. Shaw D., Ladds G., Duez P., Williamson E., Chan K. Pharmacovigilance of herbal medicine. J Ethnopharmacol: 2012; 140 513 518
6. Zhang L., Yan J., Liu X., Ye Z., Yang X., Meyboom R., Chan K., Shaw D., Duez P. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. J Ethnopharmacol: 2012; 140 519 525
7. Biringanine G., Vray B., Vercruysse V., Vanhaelen-Fastre R., Vanhaelen M., Duez P. Polysaccharides extracted from the leaves of Plantago palmata Hook.f. induce nitric oxide and tumor necrosis factor-alpha production by interferon-gamma-activated macrophages. Nitr Oxide: 2005; 12 1 8
8. Santos N. C., Figueira-Coelho J., Martins-Silva J., Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol: 2003; 65 1035 1041
9. Ponzio G., Loubat A., Rochet N., Turchi L., Rezzonico R., Farahi Far D., Dulic V., Rossi B. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and 21[CIP1] induction. Oncogene: 1998; 17 1159 1166
10. Julien C., Marcouiller F., Bretteville A., El Khoury N. B., Baillargeon J., Hebert S. S., Planel E. Dimethyl sulfoxide induces both direct and indirect tau hyperphosphorylation. PLoS One: 2012; 7 e40020
11. David R. M., Jones H. S., Panter G. H., Winter M. J., Hutchinson T. H., Kevin Chipman J. Interference with xenobiotic metabolic activity by the commonly used vehicle solvents dimethylsulfoxide and methanol in zebrafish (Danio rerio) larvae but not Daphnia magna. Chemosphere: 2012; 88 912 917
12. Da Violante G., Zerrouk N., Richard I., Provot G., Chaumeil J. C., Arnaud P. Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures. Biol Pharm Bull: 2002; 25 1600 1603
13. Tice R. R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J. C., Sasaki Y. F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen: 2000; 35 206 221
14. Charles C., Chemais M., Stevigny C., Dubois J., Nachergael A., Duez P. Measurement of the influence of flavonoids on DNA repair kinetics using the comet assay. Food Chem: 2012; 135 2974 2981
15. Galluzzi L., Vitale I., Abrams J. M., Alnemri E. S., Baehrecke E. H., Blagosklonny M. V., Dawson T. M., Dawson V. L., El-Deiry W. S., Fulda S., Gottlieb E., Green D. R., Hengartner M. O., Kepp O., Knight R. A., Kumar S., Lipton S. A., Lu X., Madeo F., Malorni W., Mehlen P., Nunez G., Peter M. E., Piacentini M., Rubinsztein D. C., Shi Y., Simon H. U., Vandenabeele P., White E., Yuan J., Zhivotovsky B., Melino G., Kroemer G. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ: 2012; 19 107 120
16. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E. S., Baehrecke E. H., Blagosklonny M. V., El-Deiry W. S., Golstein P., Green D. R., Hengartner M., Knight R. A., Kumar S., Lipton S. A., Malorni W., Nunez G., Peter M. E., Tschopp J., Yuan J., Piacentini M., Zhivotovsky B., Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ: 2009; 16 3 11
17. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol: 1995; 146 3 15
18. Schwartzman R. A., Cidlowski J. A. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev: 1993; 14 133 151
19. Hotchkiss R. S., Strasser A., McDunn J. E., Swanson P. E. Cell death. N Engl J Med: 2009; 361 1570 1583
20. Krysko D. V., Vanden Berghe T., D'Herde K., Vandenabeele P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods: 2008; 44 205 221
21. Proskuryakov S. Y., Konoplyannikov A. G., Gabai V. L. Necrosis: a specific form of programmed cell death? Exp Cell Res: 2003; 283 1 16
22. Zhivotovsky B. Apoptosis, necrosis and between. Cell Cycle: 2004; 3 64 66
23. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol: 2007; 35 495 516
24. Ward T. H., Cummings J., Dean E., Greystoke A., Hou J. M., Backen A., Ranson M., Dive C. Biomarkers of apoptosis. Br J Cancer: 2008; 99 841 846
25. Kiechle F. L., Zhang X. Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta: 2002; 326 27 45
26. Shen H. M., Codogno P. Autophagy is a survival force via suppression of necrotic cell death. Exp Cell Res: 2012; 318 1304 1308
27. Korsnes M. S., Espenes A., Hetland D. L., Hermansen L. C. Paraptosis-like cell death induced by yessotoxin. Toxicol In Vitro: 2011; 25 1764 1770
28. Sperandio S., de Belle I., Bredesen D. E. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA: 2000; 97 14376 14381
29. Sperandio S., Poksay K., de Belle I., Lafuente M. J., Liu B., Nasir J., Bredesen D. E. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ: 2004; 11 1066 1075
30. Yoon M. J., Kim E. H., Kwon T. K., Park S. A., Choi K. S. Simultaneous mitochondrial Ca(2+) overload and proteasomal inhibition are responsible for the induction of paraptosis in malignant breast cancer cells. Cancer Lett: 2012; 324 197 209
31. Fink S. L., Cookson B. T. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun: 2005; 73 1907 1916
32. Slater T. F., Sawyer B., Straeuli U. Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta: 1963; 77 383 393
33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods: 1983; 65 55 63
34. Berridge M. V., Tan A. S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys: 1993; 303 474 482
35. Berridge M. V., Herst P. M., Tan A. S. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev: 2005; 11 127 152
36. Scudiero D. A., Shoemaker R. H., Paull K. D., Monks A., Tierney S., Nofziger T. H., Currens M. J., Seniff D., Boyd M. R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res: 1988; 48 4827 4833
37. Goodwin C. J., Holt S. J., Downes S., Marshall N. J. Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J Immunol Methods: 1995; 179 95 103
38. Shoemaker M., Cohen I., Campbell M. Reduction of MTT by aqueous herbal extracts in the absence of cells. J Ethnopharmacol: 2004; 93 381 384
39. Bruggisser R., von Daeniken K., Jundt G., Schaffner W., Tullberg-Reinert H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med: 2002; 68 445 448
40. Wisman K. N., Perkins A. A., Jeffers M. D., Hagerman A. E. Accurate assessment of the bioactivities of redox-active polyphenolics in cell culture. J Agric Food Chem: 2008; 56 7831 7837
41. Wang P., Henning S. M., Heber D. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One: 2010; 5 e10202
42. Muraina I. A., Suleiman M. M., Eloff J. N. Can MTT be used to quantify the antioxidant activity of plant extracts? Phytomedicine: 2009; 16 665 668
43. Pagliacci M. C., Spinozzi F., Migliorati G., Fumi G., Smacchia M., Grignani F., Riccardi C., Nicoletti I. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur J Cancer: 1993; 29?A 1573 1577
44. Naoi T., Shibuya N., Inoue H., Mita S., Kobayashi S., Watanabe K., Orino K. The effect of tert-butylhydroquinone-induced oxidative stress in MDBK cells using XTT assay: implication of tert-butylhydroquinone-induced NADPH generating enzymes. J Vet Med Sci: 2010; 72 321 326
45. Hamid R., Rotshteyn Y., Rabadi L., Parikh R., Bullock P. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro: 2004; 18 703 710
46. Thorne N., Auld D. S., Inglese J. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr Opin Chem Biol: 2010; 14 315 324
47. Yu H. G., Chung H., Yu Y. S., Seo J. M., Heo J. W. A new rapid and non-radioactive assay for monitoring and determining the proliferation of retinal pigment epithelial cells. Korean J Ophthalmol: 2003; 17 29 34
48. Zhi-Jun Y., Sriranganathan N., Vaught T., Arastu S. K., Ansar Ahmed S. A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. J Immunol Methods: 1997; 210 25 39
49. Erikstein B. S., Hagland H. R., Nikolaisen J., Kulawiec M., Singh K. K., Gjertsen B. T., Tronstad K. J. Cellular stress induced by resazurin leads to autophagy and cell death via production of reactive oxygen species and mitochondrial impairment. J Cell Biochem: 2010; 111 574 584
50. Goegan P., Johnson G., Vincent R. Effects of serum protein and colloid on the alamarBlue assay in cell cultures. Toxicol In Vitro: 1995; 9 257 266
51. Repetto G., del Peso A., Zurita J. L. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc: 2008; 3 1125 1131
52. Borenfreund E., Puerner J. A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett: 1985; 24 119 124
53. Hall J. O., Novakofski J. E., Beasley V. R. Neutral red assay modification to prevent cytotoxicity and improve reproducibility using E-63 rat skeletal muscle cells. Biotechnol Histochem: 1998; 73 211 221
54. Higashi T., Isomoto A., Tyuma I., Kakishita E., Uomoto M., Nagai K. Quantitative and continuous analysis of ATP release from blood platelets with firefly luciferase luminescence. Thromb Haemost: 1985; 53 65 69
55. Crouch S. P., Kozlowski R., Slater K. J., Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods: 1993; 160 81 88
56. Squatrito R. C., Connor J. P., Buller R. E. Comparison of a novel redox dye cell growth assay to the ATP bioluminescence assay. Gynecol Oncol: 1995; 58 101 105
57. Fan F., Wood K. V. Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol: 2007; 5 127 136
58. Ulukaya E., Ozdikicioglu F., Oral A. Y., Demirci M. The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested. Toxicol In Vitro: 2008; 22 232 239
59. Thorne N., Inglese J., Auld D. S. Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology. Chem Biol: 2010; 17 646 657
60. Bakhtiarova A., Taslimi P., Elliman S. J., Kosinski P. A., Hubbard B., Kavana M., Kemp D. M. Resveratrol inhibits firefly luciferase. Biochem Biophys Res Commun: 2006; 351 481 484
61. Leitao J. M., Esteves da Silva J. C. Firefly luciferase inhibition. J Photochem Photobiol B: 2010; 101 1 8
62. Shimomura Y., Kawada T., Suzuki M. Capsaicin and its analogs inhibit the activity of NADH-coenzyme Q oxidoreductase of the mitochondrial respiratory chain. Arch Biochem Biophys: 1989; 270 573 577
63. Cheng S. C., Pardini R. S. Structure-inhibition relationships of various phenolic compounds towards mitochondrial respiration. Pharmacol Res Commun: 1978; 10 897 910
64. Gledhill J. R., Montgomery M. G., Leslie A. GW, Walker J. E. Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc Natl Acad Sci USA: 2007; 104 13632 13637
65. Chan G. K., Kleinheinz T. L., Peterson D., Moffat J. G. A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays. PLoS One: 2013; 8 e63583
66. Kitami T., Logan D. J., Negri J., Hasaka T., Tolliday N. J., Carpenter A. E., Spiegelman B. M., Mootha V. K. A chemical screen probing the relationship between mitochondrial content and cell size. PLoS One: 2012; 7 e33755
67. Kluza J., Marchetti P., Gallego M. A., Lancel S., Fournier C., Loyens A., Beauvillain J. C., Bailly C. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene: 2004; 23 7018 7030
68. Renner K., Amberger A., Konwalinka G., Kofler R., Gnaiger E. Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells. Biochim Biophys Acta: 2003; 1642 115 123
69. Abe K., Matsuki N. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. Neurosci Res: 2000; 38 325 329
70. Korzeniewski C., Callewaert D. M. An enzyme-release assay for natural cytotoxicity. J Immunol Methods: 1983; 64 313 320
71. Weyermann J., Lochmann D., Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm: 2005; 288 369 376
72. Schofield P., Mbugua D. M., Pell A. N. Analysis of condensed tannins: a review. Anim Feed Sci Technol: 2001; 91 21 40
73. Bruneton J. Pharmacognosie: Phytochimie, Plantes médicinales, 4th edition. Paris Lavoisier: 2009
74. Goldstein J. L., Swain T. The inhibition of enzymes by tannins. Phytochemistry: 1965; 4 185 192
75. Kendig D. M., Tarloff J. B. Inactivation of lactate dehydrogenase by several chemicals: implications for in vitro toxicology studies. Toxicol In Vitro: 2007; 21 125 132
76. Bottger S., Hofmann K., Melzig M. F. Saponins can perturb biologic membranes and reduce the surface tension of aqueous solutions: a correlation? Bioorg Med Chem: 2012; 20 2822 2828
77. Grankvist K., Lernmark A., Taljedal I. B. Alloxan cytotoxicity in vitro. Microscope photometric analyses of Trypan Blue uptake by pancreatic islet cells in suspension. Biochem J: 1977; 162 19 24
78. Uliasz T. F., Hewett S. J. A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture. J Neurosci Methods: 2000; 100 157 163
79. Hu J., el-Fakahany E. E. An artifact associated with using trypan blue exclusion to measure effects of amyloid beta on neuron viability. Life Sci: 1994; 55 1009 1016
80. Johnson I., Spence M. The Molecular Probes® Handbook, 11th edition, Section 12.5. Available at http://www.lifetechnologies.com/be/en/home/references/molecular-probes-the-handbook.html Accessed December 11, 2013.
81. Sonnenbichler J., Scalera F., Sonnenbichler I., Weyhenmeyer R. Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells. J Pharmacol Exp Ther: 1999; 290 1375 1383
82. Nunez R. DNA measurement and cell cycle analysis by flow cytometry. Curr Issues Mol Biol: 2001; 3 67 70
83. Nicoletti I., Migliorati G., Pagliacci M. C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods: 1991; 139 271 279
84. Taupin P. BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res Rev: 2007; 53 198 214
85. Munshi A., Hobbs M., Meyn R. Clonogenic cell survival assay. In: Blumenthal R. D. editor Methods in molecular medicine. Totawa Humana Press: 2005; 21 28
86. Franken N. A., Rodermond H. M., Stap J., Haveman J., van Bree C. Clonogenic assay of cells in vitro. Nat Protoc: 2006; 1 2315 2319
87. Quto b S. S., Ng C. E. Comparison of apoptotic, necrotic and clonogenic cell death and inhibition of cell growth following camptothecin and X-radiation treatment in a human melanoma and a human fibroblast cell line. Cancer Chemother Pharmacol: 2002; 49 167 175
88. Saraste A. Morphologic criteria and detection of apoptosis. Herz: 1999; 24 189 195
89. Wang C., Jiang Z., Yao J., Wu X., Sun L., Liu C., Duan W., Yan M., Liu J., Zhang L. Participation of cathepsin B in emodin-induced apoptosis in HK-2 cells. Toxicol Lett: 2008; 181 196 204
90. Galluzzi L., Aaronson S. A., Abrams J., Alnemri E. S., Andrews D. W., Baehrecke E. H., Bazan N. G., Blagosklonny M. V., Blomgren K., Borner C., Bredesen D. E., Brenner C., Castedo M., Cidlowski J. A., Ciechanover A., Cohen G. M., De Laurenzi V., De Maria R., Deshmukh M., Dynlacht B. D., El-Deiry W. S., Flavell R. A., Fulda S., Garrido C., Golstein P., Gougeon M. L., Green D. R., Gronemeyer H., Hajnoczky G., Hardwick J. M., Hengartner M. O., Ichijo H., Jaattela M., Kepp O., Kimchi A., Klionsky D. J., Knight R. A., Kornbluth S., Kumar S., Levine B., Lipton S. A., Lugli E., Madeo F., Malomi W., Marine J. C., Martin S. J., Medema J. P., Mehlen P., Melino G., Moll U. M., Morselli E., Nagata S., Nicholson D. W., Nicotera P., Nunez G., Oren M., Penninger J., Pervaiz S., Peter M. E., Piacentini M., Prehn J. H., Puthalakath H., Rabinovich G. A., Rizzuto R., Rodrigues C. M., Rubinsztein D. C., Rudel T., Scorrano L., Simon H. U., Steller H., Tschopp J., Tsujimoto Y., Vandenabeele P., Vitale I., Vousden K. H., Youle R. J., Yuan J., Zhivotovsky B., Kroemer G. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ: 2009; 16 1093 1107
91. Bury M., Novo-Uzal E., Andolfi A., Cimini S., Wauthoz N., Heffeter P., Lallemand B., Avolio F., Delporte C., Cimmino A., Dubois J., Van Antwerpen P., Zonno M. C., Vurro M., Poumay Y., Berger W., Evidente A., De Gara L., Kiss R., Locato V. Ophiobolin A, a sesterterpenoid fungal phytotoxin, displays higher in vitro growth-inhibitory effects in mammalian than in plant cells and displays in vivo antitumor activity. Int J Oncol: 2013; 43 575 585
92. Nacoulma A. Reprogrammation métabolique induite dans les tissus hyperplasique formés chez le tabac infecté par Rodococcusfascians: aspects fondamentaux et applications potentielles [PhD Thesis]. Brussels Université Libre de Bruxelles: 2013
93. Debeir O., Megalizzi V., Warzee N., Kiss R., Decaestecker C. Videomicroscopic extraction of specific information on cell proliferation and migration in vitro. Exp Cell Res: 2008; 314 2985 2998
94. Hu Q., Noor M., Wong Y. F., Hylands P. J., Simmonds M. S., Xu Q., Jiang D., Hendry B. M. In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transplant: 2009; 24 3033 3041
95. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods: 1995; 184 39 51
96. Verzola D., Gandolfo M. T., Salvatore F., Villaggio B., Gianiorio F., Traverso P., Deferrari G., Garibotto G. Testosterone promotes apoptotic damage in human renal tubular cells. Kidney Int: 2004; 65 1252 1261
97. Jacob M. C., Favre M., Bensa J. C. Membrane cell permeabilization with saponin and multiparametric analysis by flow cytometry. Cytometry: 1991; 12 550 558
98. Wang C., Wu X., Chen M., Duan W., Sun L., Yan M., Zhang L. Emodin induces apoptosis through caspase 3-dependent pathway in HK-2 cells. Toxicology: 2007; 231 120 128
99. Fan C., Wang W., Zhao B., Zhang S., Miao J. Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Bioorg Med Chem: 2006; 14 3218 3222
100. Li B. Chaine respiratoire et pore de transition de permeabilité mitochondriale dans la cardioprotection [PhD Thesis]. Lyon Université Claude Bernard: 2009
101. Zhu B., Zhai Q., Yu B. Tanshinone IIA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition. Pharm Biol: 2010; 48 484 487
102. Baumann S., Fas S. C., Giaisi M., Muller W. W., Merling A., Gulow K., Edler L., Krammer P. H., Li-Weber M. Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis. Blood: 2008; 111 2354 2363
103. Singh N. P., McCoy M. T., Tice R. R., Schneider E. L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res: 1988; 175 184 191
104. Fairbairn D. W., Olive P. L., O'Neill K. L. The comet assay: a comprehensive review. Mutat Res: 1995; 339 37 59
105. Anderson D., Yu T. W., McGregor D. B. Comet assay responses as indicators of carcinogen exposure. Mutagenesis: 1998; 13 539 555
106. Rojas E., Lopez M. C., Valverde M. Single cell gel electrophoresis assay: methodology and applications. J Chromatogr B Biomed Sci Appl: 1999; 722 225 254
107. Hartmann A., Speit G. The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol Lett: 1997; 90 183 188
108. Horvathova E., Dusinska M., Shaposhnikov S., Collins A. R. DNA damage and repair measured in different genomic regions using the comet assay with fluorescent in situ hybridization. Mutagenesis: 2004; 19 269 276
109. Gedik C. M., Ewen S. W., Collins A. R. Single-cell gel electrophoresis applied to the analysis of UV-C damage and its repair in human cells. Int J Radiat Biol: 1992; 62 313 320
110. Olive P. L. DNA damage and repair in individual cells: applications of the comet assay in radiobiology. Int J Radiat Biol: 1999; 75 395 405
111. Bocker W., Bauch T., Muller W. U., Streffer C. Image analysis of comet assay measurements. Int J Radiat Biol: 1997; 72 449 460
112. Olive P. L., Banath J. P., Durand R. E. Heterogeneity in radiation induced DNA damage and repair in tumor and normal cells measured using the 'comet' assay. Radiat Res: 1990; 122 86 94
113. Speit G., Vasquez M., Hartmann A. The comet assay as an indicator test for germ cell genotoxicity. Mutat Res: 2009; 681 3 12
114. Berthelot-Ricou A., Perrin J., Di Giorgio C., De Meo M., Botta A., Courbiere B. Comet assay on mouse oocytes: an improved technique to evaluate genotoxic risk on female germ cells. Fertil Steril: 2011; 95 1452 1457
115. Duez P., Dehon G., Kumps A., Dubois J. Statistics of the Comet assay: a key to discriminate between genotoxic effects. Mutagenesis: 2003; 18 159 166
116. Speit G., Brendler-Schwaab S., Hartmann A., Pfuhler S. The in vivo comet assay: use and status in genotoxicity testing. Mutagenesis: 2005; 20 245 254
117. Kim Y. J., Park H. J., Yoon S. H., Kim M. J., Leem K. H., Chung J. H., Kim H. K. Anticancer effects of oligomeric proanthocyanidins on human colorectal cancer cell line, SNU-C4. World J Gastroenterol: 2005; 11 4674 4678
118. Martins C., Doran C., Laires A., Rueff J., Rodrigues A. S. Genotoxic and apoptotic activities of the food flavourings myristicin and eugenol in AA8 and XRCC1 deficient EM9 cells. Food Chem Toxicol: 2011; 49 385 392
119. Heatwole V. M. TUNEL assay for apoptotic cells. Methods Mol Biol: 1999; 115 141 148
120. Stahelin B. J., Marti U., Solioz M., Zimmermann H., Reichen J. False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate. Mol Pathol: 1998; 51 204 208
121. Bonner W. M., Redon C. E., Dickey J. S., Nakamura A. J., Sedelnikova O. A., Solier S., Pommier Y. GammaH2AX and cancer. Nat Rev Cancer: 2008; 8 957 967
122. Muslimovic A., Ismail I. H., Gao Y., Hammarsten O. An optimized method for measurement of gamma-H2AX in blood mononuclear and cultured cells. Nat Protoc: 2008; 3 1187 1193
123. Smart D. J., Ahmedi K. P., Harvey J. S., Lynch A. M. Genotoxicity screening via the gammaH2AX by flow assay. Mutat Res: 2011; 715 25 31
124. Verschaeve L., Juutilainen J., Lagroye I., Miyakoshi J., Saunders R., de Seze R., Tenforde T., van Rongen E., Veyret B., Xu Z. In vitro and in vivo genotoxicity of radiofrequency fields. Mutat Res: 2010; 705 252 268
125. Sedelnikova O. A., Rogakou E. P., Panyutin I. G., Bonner W. M. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res: 2002; 158 486 492
126. Bouquet F., Muller C., Salles B. The loss of gamma H2AX signal is a marker of DNA double strand breaks repair only a low levels of DNA damage. Cell Cycle: 2006; 5 1116 1122
127. Maron D. M., Ames B. N. Revised methods for the Salmonella mutagenicity test. Mutat Res: 1983; 113 173 215
128. Ramos A., Edreira A., Vizoso A., Betancourt J., Lopez M., Decalo M. Genotoxicity of an extract of Calendula officinalis L. J Ethnopharmacol: 1998; 61 49 55
129. Zhang H., Cifone M. A., Murli H., Erexson G. L., Mecchi M. S., Lawlor T. E. Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid. Food Chem Toxicol: 2004; 42 2021 2028
130. Ogura R., Ikeda N., Yuki K., Morita O., Saigo K., Blackstock C., Nishiyama N., Kasamatsu T. Genotoxicity studies on green tea catechin. Food Chem Toxicol: 2008; 46 2190 2200
131. EMEA Overview of comments received on draft 'guideline on the assessment of genotoxic constituents in herbal Substances/preparations' (emea/hmpc/107079/2007). Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Other/2009/09/WC500003570.pdf Accessed August 2013.
132. Bolognesi C. Genotoxicity of pesticides: a review of human biomonitoring studies. Mutat Res: 2003; 543 251 272
133. Fenech M. The in vitro m icronucleus technique. Mutat Res: 2000; 455 81 95
134. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M. jr., Kirchner S., Lorge E., Morita T., Norppa H., Surralles J., Vanhauwaert A., Wakata A. Report from the in vitro micronucleus assay working group. Mutat Res: 2003; 540 153 163
135. OECD OECD guideline for the testing of chemicals: mammalian erythrocyte micronucleus test. Chemical safety and biosafety 1997; Testing of chemicals. Available at http://www.oecd.org/chemicalsafety/testing/oecdguidelinesforthetestingofchemicals.htm Accessed December 11, 2013.
136. Westerink W. M., Schirris T. J., Horbach G. J., Schoonen W. G. Development and validation of a high-content screening in vitro micronucleus assay in CHO-k1 and HepG2 cells. Mutat Res: 2011; 724 7 21
137. Lambert I. B., Singer T. M., Boucher S. E., Douglas G. R. Detailed review of transgenic rodent mutation assays. Mutat Res: 2005; 590 1 280
138. Bakkali F., Averbeck S., Averbeck D., Idaomar M. Biological effects of essential oils - a review. Food Chem Toxicol: 2008; 46 446 475
139. Droge W. Free radicals in the physiological control of cell function. Physiol Rev: 2002; 82 47 95
140. Zhao B. L., Li X. J., He R. G., Cheng S. J., Xin W. J. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys: 1989; 14 175 185
141. Abenavoli L., Capasso R., Milic N., Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res: 2010; 24 1423 1432
142. Paya M., Halliwell B., Hoult J. R. Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem Pharmacol: 1992; 44 205 214
143. Carr A., Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J: 1999; 13 1007 1024
144. Lapidot T., Walker M. D., Kanner J. Can apple antioxidants inhibit tumor cell proliferation? Generation of H(2)O(2) during interaction of phenolic compounds with cell culture media. J Agric Food Chem: 2002; 50 3156 3160
145. O'Brien P. J. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact: 1991; 80 1 41
146. Brisson M., Nguyen T., Wipf P., Joo B., Day B. W., Skoko J. S., Schreiber E. M., Foster C., Bansal P., Lazo J. S. Redox regulation of Cdc25B by cell-active quinolinediones. Mol Pharmacol: 2005; 68 1810 1820
147. Vasquez D. R., Verrax J., Valderrama J. A., Calderon P. B. Aminopyrimidoisoquinolinequinone (APIQ) redox cycling is potentiated by ascorbate and induces oxidative stress leading to necrotic-like cancer cell death. Invest New Drugs: 2012; 30 1003 1011
148. Gomes A., Fernandes E., Lima J. L. Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods: 2005; 65 45 80
149. Eruslanov E., Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol: 2010; 594 57 72
150. Wardman P. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic Biol Med: 2007; 43 995 1022
151. Saengkhae C., Loetchutinat C., Garnier-Suillerot A. Kinetic analysis of fluorescein and dihydrofluorescein effluxes in tumour cells expressing the multidrug resistance protein, MRP1. Biochem Pharmacol: 2003; 65 969 977
152. Hempel S. L., Buettner G. R., O'Malley Y. Q., Wessels D. A., Flaherty D. M. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med: 1999; 27 146 159
153. Pompella A., Visvikis A., Paolicchi A., De Tata V., Casini A. F. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol: 2003; 66 1499 1503
154. Baker M. A., Cerniglia G. J., Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem: 1990; 190 360 365
155. Gallwitz H., Bonse S., Martinez-Cruz A., Schlichting I., Schumacher K., Krauth-Siegel R. L. Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic, kinetic, and spectroscopic studies. J Med Chem: 1999; 42 364 372
156. Rice G. C., Bump E. A., Shrieve D. C., Lee W., Kovacs M. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res: 1986; 46 6105 6110
157. Kim D. P., Yahav J., Sperandeo M., Maloney L., McTigue M., Lin F., Clark R. A. High cell density attenuates reactive oxygen species: implications for in vitro assays. Wound Repair Regen: 2012; 20 74 82
158. Patton S., Kurtz G. W. 2-Thiobarbituric acid as a reagent for detecting milk fat oxidation. J Dairy Sci: 1951; 34 669 674
159. Guillen-Sans R., Guzman-Chozas M. The thiobarbituric acid (TBA) reaction in foods: a review. Crit Rev Food Sci Nutr: 1998; 38 315 330
160. Lefevre G., Beljean-Leymarie M., Beyerle F., Bonnefont-Rousselot D., Cristol J. P., Therond P., Torreilles J. [Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances]. Ann Biol Clin (Paris): 1998; 56 305 319
161. Louzao M. C., Ares I. R., Cagide E., Espina B., Vilarino N., Alfonso A., Vieytes M. R., Botana L. M. Palytoxins and cytoskeleton: An overview. Toxicon: 2011; 57 460 469
162. Peterson J. R., Mitchison T. J. Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. Chem Biol: 2002; 9 1275 1285
163. Borisy G. G., Taylor E. W. The mechanism of action of colchicine. Binding of colchincine-3H to cellular protein. J Cell Biol: 1967; 34 525 533
164. Nicolaou K. C., Finlay M. R., Ninkovic S., King N. P., He Y., Li T., Sarabia F., Vourloumis D. Synthesis and biological properties of C12, 13-cyclopropyl-epothilone A and related epothilones. Chem Biol: 1998; 5 365 372
165. Small J., Rottner K., Hahne P., Anderson K. I. Visualising the actin cytoskeleton. Microsc Res Tech: 1999; 47 3 17
166. Hayot C., Debeir O., Van Ham P., Van Damme M., Kiss R., Decaestecker C. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol Appl Pharmacol: 2006; 211 30 40
167. Simmons S. O., Fan C. Y., Ramabhadran R. Cellular stress response pathway system as a sentinel ensemble in toxicological screening. Toxicol Sci: 2009; 111 202 225
168. Tsien R. Y. The green fluorescent protein. Annu Rev Biochem: 1998; 67 509 544
169. Crawford A. D., Esguerra C. V., de Witte P. A. Fishing for drugs from nature: zebrafish as a technology platform for natural product discovery. Planta Med: 2008; 74 624 632
170. Borner F. U., Schutz H., Wiedemann P. The fragility of omics risk and benefit perceptions. Toxicol Lett: 2011; 201 249 257
171. Bishop W. E., Clarke D. P., Travis C. C. The genomic revolution: what does it mean for risk assessment? Risk Anal: 2001; 21 983 987
172. Heijne W. H., Kienhuis A. S., van Ommen B., Stierum R. H., Groten J. P. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology. Expert Rev Proteomics: 2005; 2 767 780
173. Aardema M. J., MacGregor J. T. Toxicology and genetic toxicology in the new era of toxicogenomics: impact of -omics technologies. Mutat Res: 2002; 499 13 25
174. Marchant G. E. Toxicogenomics and toxic torts. Trends Biotechnol: 2002; 20 329 332
175. Marques A., Lourenço H. M., Nunes M. L., Roseiro C., Santos C., Barranco A., Rainieri S., Langerholc T., Cencic A. New tools to assess toxicity, bioaccessibility and uptake of chemical contaminants in meat and seafood. Food Res Int: 2011; 44 510 522
176. Lay J. O. jr., Borgmann S., Liyanage R., Wilkins C. L. Problems with the omics Trends Anal Chem: 2006; 25 1046 1056
177. Searfoss G. H., Ryan T. P., Jolly R. A. The role of transcriptome analysis in pre-clinical toxicology. Curr Mol Med: 2005; 5 53 64
178. Ouedraogo M., Baudoux T., Stevigny C., Nortier J., Colet J. M., Efferth T., Qu F., Zhou J., Chan K., Shaw D., Pelkonen O., Duez P. Review of current and omics methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms. J Ethnopharmacol: 2012; 140 492 512
179. Selderslaghs I. W., Blust R., Witters H. E. Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. Reprod Toxicol: 2012; 33 142 154
180. Blechinger S. R., Warren J. T. jr., Kuwada J. Y., Krone P. H. Developmental toxicology of cadmium in living embryos of a stable transgenic zebrafish line. Environ Health Perspect: 2002; 110 1041 1046
181. Van Raamsdonk J. M., Hekimi S. Reactive oxygen species and aging in Caenorhabditis elegans: causal or casual relationship? Antioxid Redox Signal: 2010; 13 1911 1953
182. Brenner S. The genetics of Caenorhabditis elegans. Genetics: 1974; 77 71 94
183. Leung M. C., Williams P. L., Benedetto A., Au C., Helmcke K. J., Aschner M., Meyer J. N. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci: 2008; 106 5 28
184. Gnoula C., Guissou I., Dubois J., Duez P. 5(6)-Carboxyfluorescein diacetate as an indicator of Caenorhabditis elegans viability for the development of an in vitro anthelmintic drug assay. Talanta: 2007; 71 1886 1892
185. Valerio L. G. jr. In silico toxicology for the pharmaceutical sciences. Toxicol Appl Pharmacol: 2009; 241 356 370